Di-tert-butyl 2-(6-iodopyridazin-3-yl)malonate

Catalog No.: 
ACDUSZ275
CAS No.: 
1853166-10-5
Molecular Formula: 
C15H21IN2O4
Molecular Weight: 
420.25
Di-tert-butyl 2-(6-iodopyridazin-3-yl)malonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$596.00InquiryInquiry
1g97%$1477.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDi-tert-butyl 2-(6-iodopyridazin-3-yl)malonate
IUPAC Namedi-tert-butyl 2-(6-iodopyridazin-3-yl)malonate
MDL No.MFCD30471951
Molecular FormulaC15H21IN2O4
Molecular Weight420.25
SMILESO=C(OC(C)(C)C)C(C1=NN=C(I)C=C1)C(OC(C)(C)C)=O
InChI KeyXQGBKHCSCXVNGA-UHFFFAOYSA-N
SynonymPropanedioic acid, 2-(6-iodo-3-pyridazinyl)-, 1,3-bis(1,1-dimethylethyl) ester
CAS No.1853166-10-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACDUSZ275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMCKJ042 route compound structure diagram
    ACMCKJ04220698-04-8In Stock
  4. Then
  5. ACDUSZ275 route product structure diagram
    ACDUSZ2751853166-10-5
Inquiry

2. ACDUSZ275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDUSZ275 route product structure diagram
    ACDUSZ2751853166-10-5
Inquiry

3. ACDUSZ275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDUSZ275 route product structure diagram
    ACDUSZ2751853166-10-5
Inquiry

Comments (0)